The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64

被引:84
作者
Cormier, RT
Bilger, A
Lillich, AJ
Halberg, RB
Hong, KH
Gould, KA
Borenstein, N
Lander, ES
Dove, WF
机构
[1] Univ Wisconsin, Mcardle Lab Canc Res, Madison, WI 53706 USA
[2] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[3] MIT, Dept Biol, Cambridge, MA 02139 USA
[4] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA
关键词
Mom1; tumor resistance; Apc; Min mouse; goblet cell; Pla2g2a;
D O I
10.1038/sj.onc.1203646
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Mom1 (Modifier of Min-1) region of distal chromosome 4 was identified during a screen for polymorphic modifiers of intestinal tumorigenesis in Apc(Min/+) mice. Here, we demonstrate that the Mom1(AKR) allele consists of two genetic components. These include the secretory phospholipase Pla2g2a, whose candidacy as a Mom1 resistance modifier has now been tested with several transgenic Lines. A second region, distal to Pla2g2a, has also been identified using fine structure recombinants. Pla2g2a(AKR) transgenic mice demonstrate a modest resistance to tumorigenesis in the small intestine and a ver! robust resistance in the large intestine, Moreover, the tumor resistance in the colon of Pla2g2a(AKR) animals is dosage-dependent, a finding that is consistent with our observation that Pla2g2a is expressed in goblet cells, By contrast, mice carrying the distal Mom1 modifier demonstrate a modest tumor resistance that is confined to the small intestine. Thus. the phenotypes of these two modifier loci are complementary, both in their quantitative and regional effects. The additive effects and tight Linkage of these modifiers may have been necessary for the initial identification of the Mom1 region.
引用
收藏
页码:3182 / 3192
页数:11
相关论文
共 89 条
[1]   Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2 [J].
Balsinde, J ;
Balboa, MA ;
Dennis, EA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :7951-7956
[2]   Sulindac suppresses tumorigenesis in the Min mouse [J].
BeazerBarclay, Y ;
Levy, DB ;
Moser, AR ;
Dove, WF ;
Hamilton, SR ;
Vogelstein, B ;
Kinzler, KW .
CARCINOGENESIS, 1996, 17 (08) :1757-1760
[3]  
Boolbol SK, 1996, CANCER RES, V56, P2556
[4]  
Charalambous D, 1998, J GASTROEN HEPATOL, V13, P1195
[5]  
Chiu CH, 1997, CANCER RES, V57, P4267
[6]   Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1 [J].
Cohn, SM ;
Schloemann, S ;
Tessner, T ;
Seibert, K ;
Stenson, WF .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1367-1379
[7]   Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis [J].
Cormier, RT ;
Hong, KH ;
Halberg, RB ;
Hawkins, TL ;
Richardson, P ;
Mulherkar, R ;
Dove, WF ;
Lander, ES .
NATURE GENETICS, 1997, 17 (01) :88-91
[8]   Both group IB and group IIA secreted phospholipases A2 are natural ligands of the mouse 180-kDa M-type receptor [J].
Cupillard, L ;
Mulherkar, R ;
Gomez, N ;
Kadam, S ;
Valentin, E ;
Lazdunski, M ;
Lambeau, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7043-7051
[9]  
DENNIS EA, 1994, J BIOL CHEM, V269, P13057
[10]  
DIETRICH W, 1992, GENETICS, V131, P423